Wednesday, March 15, 2006


Hep C - Popular Science Magazine Features The Aethlon Hemopurifier(TM)


Popular Science Magazine Features The Aethlon Hemopurifier(TM)
Genetic Engineering News - Aethlon Medical is developing the first medical device to treat infectious disease. The device, known as the Hemopurifier(TM), is a broad-spectrum treatment countermeasure against drug and vaccine resistant bioweapons, naturally evolving pandemic

Hepatitis C: serum viral levels recur rapidly after liver transplant
Xagena Medical News - When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy liver transplant, virus levels rebound and can surpass pre-transplant levels within a few days. Hepatitis C is the

Viral hepatitis C management involves some tough decisions
Managed Healthcare Executive - From a care delivery standpoint, identifying and treating patients with the hepatitis C virus (HCV) is a complicated and difficult process. It's the most prevalent liver disease in the world, with as many as 300 million people afflicted with the

Human Genome tumbles on mixed drug data
Investors Business Daily - BOSTON (MarketWatch) -- Human Genome Sciences shares tumbled Tuesday following the release of mixed Phase II clinical data for its biologic drug candidate to treat hepatitis C, Albuferon. Shares of Human Genome sank 20% to close at $10.89. In a

Don't leave it to luck: Wrap it up
Jasper Booster - Jasper Booster Condoms have been around for a very long time. In fact, condom use can be traced back several thousand years. Images from about 1000 BC portray ancient Egyptian studs wearing linen sheaths but it s up for discussion as to whether